"Many hundreds of millions of cash" – it's not a drug or a therapeutic device. It's diagnostic software. The algorithm is written. The integration framework has been built and successfully deployed with a number of medical services. Regulatory approvals have been granted. No manufacturing facility or partnership is required. No distribution network is required. No back-end IT infrastructure is required. It's ready to go. Now. The tech has all the support it needs already.
But I agree with everything else in your post.
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx
Ann: ResApp receives FDA 510(k) clearance for SleepCheckRx, page-106
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online